| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 62.42B | 76.78B | 60.79B | 54.16B | 51.54B | 51.97B |
| Gross Profit | 57.62B | 65.28B | 56.03B | 52.39B | 50.05B | 48.70B |
| EBITDA | 11.88B | 20.88B | 16.14B | 14.86B | 13.63B | 9.04B |
| Net Income | 8.86B | 12.35B | 8.65B | 6.91B | 6.33B | 4.91B |
Balance Sheet | ||||||
| Total Assets | 4.56T | 4.58T | 4.51T | 4.43T | 4.29T | 4.64T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 354.16B | 428.22B | 432.51B | 347.34B | 903.76B |
| Total Debt | 329.86B | 282.55B | 304.16B | 291.39B | 208.16B | 1.09T |
| Total Liabilities | 4.35T | 4.35T | 4.30T | 4.22T | 4.09T | 4.41T |
| Stockholders Equity | 213.51B | 231.13B | 205.97B | 213.11B | 194.66B | 229.30B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 16.82B | 0.00 | 0.00 | -384.83B | 371.65B |
| Operating Cash Flow | 0.00 | 18.55B | 0.00 | 0.00 | -382.47B | 373.67B |
| Investing Cash Flow | 0.00 | -129.77B | -11.67B | 23.39B | -143.94B | -5.05B |
| Financing Cash Flow | 0.00 | 37.19B | 43.26B | 57.24B | -32.29B | -2.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥181.77B | 12.13 | ― | 2.96% | 21.41% | 42.73% | |
72 Outperform | ¥196.10B | 13.06 | ― | 2.23% | 31.23% | 66.11% | |
70 Outperform | ¥177.45B | 13.36 | 3.68% | 2.26% | 23.47% | 44.30% | |
68 Neutral | ¥169.95B | 9.78 | ― | 2.63% | 5.33% | 14.43% | |
68 Neutral | ¥192.81B | 15.92 | ― | 2.56% | 42.06% | 29.62% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥174.91B | 10.12 | ― | 2.29% | 9.41% | 45.91% |